These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 39135733)

  • 1. Connectomic insights into the impact of 1p/19q co-deletion in dominant hemisphere insular glioma patients.
    Yang ZC; Xue BW; Song XY; Yin CD; Yeh FC; Li G; Deng ZH; Sun SJ; Hou ZG; Xie J
    Front Neurosci; 2024; 18():1283518. PubMed ID: 39135733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring MGMT methylation-driven structural connectivity changes in insular gliomas: a tractography and graph theoretical analysis.
    Yang ZC; Yin CD; Yeh FC; Xue BW; Song XY; Li G; Sun SJ; Deng ZH; Hou ZG; Xie J
    J Neurooncol; 2024 Jan; 166(1):155-165. PubMed ID: 38150062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-deletion of chromosome 1p/19q and IDH1/2 mutation in glioma subsets of brain tumors in Chinese patients.
    Ren X; Cui X; Lin S; Wang J; Jiang Z; Sui D; Li J; Wang Z
    PLoS One; 2012; 7(3):e32764. PubMed ID: 22427879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High rate of deletion of chromosomes 1p and 19q in insular oligodendroglial tumors.
    Wu A; Aldape K; Lang FF
    J Neurooncol; 2010 Aug; 99(1):57-64. PubMed ID: 20035368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amide proton transfer weighted and diffusion weighted imaging based radiomics classification algorithm for predicting 1p/19q co-deletion status in low grade gliomas.
    Ma A; Yan X; Qu Y; Wen H; Zou X; Liu X; Lu M; Mo J; Wen Z
    BMC Med Imaging; 2024 Apr; 24(1):85. PubMed ID: 38600452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Diagnostic Value of Conventional MRI and CT Features in the Identification of the IDH1-Mutant and 1p/19q Co-Deletion in WHO Grade II Gliomas.
    Zhao K; Sun G; Wang Q; Xue Z; Liu G; Xia Y; Yao A; Zhao Y; You N; Yang C; Xu B
    Acad Radiol; 2021 Jul; 28(7):e189-e198. PubMed ID: 32359929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
    Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
    J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel fully automated MRI-based deep-learning method for classification of 1p/19q co-deletion status in brain gliomas.
    Yogananda CGB; Shah BR; Yu FF; Pinho MC; Nalawade SS; Murugesan GK; Wagner BC; Mickey B; Patel TR; Fei B; Madhuranthakam AJ; Maldjian JA
    Neurooncol Adv; 2020; 2(1):vdaa066. PubMed ID: 32705083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of MRI in Detecting 1p/19q Co-deletion Status of Gliomas: A Single-Center Retrospective Study.
    Naeem A; Aziz N; Nasir M; Rangwala HS; Fatima H; Mubarak F
    Cureus; 2024 Jan; 16(1):e51863. PubMed ID: 38327950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study.
    Yao J; Hagiwara A; Raymond C; Shabani S; Pope WB; Salamon N; Lai A; Ji M; Nghiemphu PL; Liau LM; Cloughesy TF; Ellingson BM
    Sci Rep; 2020 Jul; 10(1):11922. PubMed ID: 32681084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations.
    Arita H; Matsushita Y; Machida R; Yamasaki K; Hata N; Ohno M; Yamaguchi S; Sasayama T; Tanaka S; Higuchi F; Iuchi T; Saito K; Kanamori M; Matsuda KI; Miyake Y; Tamura K; Tamai S; Nakamura T; Uda T; Okita Y; Fukai J; Sakamoto D; Hattori Y; Pareira ES; Hatae R; Ishi Y; Miyakita Y; Tanaka K; Takayanagi S; Otani R; Sakaida T; Kobayashi K; Saito R; Kurozumi K; Shofuda T; Nonaka M; Suzuki H; Shibuya M; Komori T; Sasaki H; Mizoguchi M; Kishima H; Nakada M; Sonoda Y; Tominaga T; Nagane M; Nishikawa R; Kanemura Y; Kuchiba A; Narita Y; Ichimura K
    Acta Neuropathol Commun; 2020 Nov; 8(1):201. PubMed ID: 33228806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients.
    Wang K; Wang Y; Fan X; Li Y; Liu X; Wang J; Ai L; Dai J; Jiang T
    J Neurooncol; 2018 Feb; 136(3):523-531. PubMed ID: 29230668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas.
    Zhang Y; Xie Y; He L; Tang J; He Q; Cao Q; Cui L; Guo W; Hua K; Dimberg A; Wang L; Zhang L
    Cell Oncol (Dordr); 2021 Feb; 44(1):193-204. PubMed ID: 32915415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.
    Han Y; Xie Z; Zang Y; Zhang S; Gu D; Zhou M; Gevaert O; Wei J; Li C; Chen H; Du J; Liu Z; Dong D; Tian J; Zhou D
    J Neurooncol; 2018 Nov; 140(2):297-306. PubMed ID: 30097822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Parametric Radiomic Model to Predict 1p/19q Co-Deletion in Patients with IDH-1 Mutant Glioma: Added Value to the T2-FLAIR Mismatch Sign.
    Kihira S; Derakhshani A; Leung M; Mahmoudi K; Bauer A; Zhang H; Polson J; Arnold C; Tsankova NM; Hormigo A; Salehi B; Pham N; Ellingson BM; Cloughesy TF; Nael K
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens.
    Pallavajjala A; Haley L; Stinnett V; Adams E; Pallavajjala R; Huang J; Morsberger L; Hardy M; Long P; Gocke CD; Eshleman JR; Rodriguez FJ; Zou YS
    Hum Pathol; 2022 Aug; 126():63-76. PubMed ID: 35561840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma.
    Hu X; Martinez-Ledesma E; Zheng S; Kim H; Barthel F; Jiang T; Hess KR; Verhaak RGW
    Neuro Oncol; 2017 Jun; 19(6):786-795. PubMed ID: 28340142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI Scoring Systems for Predicting Isocitrate Dehydrogenase Mutation and Chromosome 1p/19q Codeletion in Adult-type Diffuse Glioma Lacking Contrast Enhancement.
    Kang KM; Song J; Choi Y; Park C; Park JE; Kim HS; Park SH; Park CK; Choi SH
    Radiology; 2024 May; 311(2):e233120. PubMed ID: 38713025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altering patterns of sensorimotor network in patients with different pathological diagnoses and glioma-related epilepsy under the latest glioma classification of the central nervous system.
    Fang S; Li L; Weng S; Guo Y; Fan X; Jiang T; Wang Y
    CNS Neurosci Ther; 2023 May; 29(5):1368-1378. PubMed ID: 36740245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Radiomics Analysis of 1p/19q Status in WHO Grade II Gliomas.
    Fan Z; Sun Z; Fang S; Li Y; Liu X; Liang Y; Liu Y; Zhou C; Zhu Q; Zhang H; Li T; Li S; Jiang T; Wang Y; Wang L
    Front Oncol; 2021; 11():616740. PubMed ID: 34295805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.